Ludwig Institut für Krebsforschung AG

🇨🇭Switzerland

Country: 🇨🇭Switzerland

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Monoclonal Antibody Therapy in Treating Patients With Advanced Colorectal Cancer

Phase 1

Terminated

Conditions: Colorectal Cancer

Interventions: Biological: monoclonal antibody hu3S193

First Posted Date: 2003-05-21

Last Posted Date: 2023-10-04

Lead Sponsor: Ludwig Institute for Cancer Research

Target Recruit Count: 7

Registration Number: NCT00006046

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy